Henry J. Fuchs, President, Worldwide R&D at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 15,000 shares at $90.50 ($1.4M) on 2017-09-15, disclosed to the SEC on 2017-09-19.
Open-market sale of $1.4M BMRN by President, Worldwide R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MRTX | SELL | 2022-02-14 | $1.4M | — | Filing → |
| MRTX | SELL | 2020-12-16 | $4.7M | — | Filing → |
| MRTX | SELL | 2020-08-11 | $1.6M | — | Filing → |